Ausgabe 2/2004
Inhalt (10 Artikel)
Introductory comments to Symposium in Writing: inhibitors of immunosurveillence and anti-tumor immunity
Suzanne Ostrand-Rosenberg
Derangement of immune responses by myeloid suppressor cells
Paolo Serafini, Carmela De Santo, Ilaria Marigo, Sara Cingarlini, Luigi Dolcetti, Giovanna Gallina, Paola Zanovello, Vincenzo Bronte
Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells
Wei-Zen Wei, Gerald P. Morris, Yi-chi M. Kong
Role of IL-13 in regulation of anti-tumor immunity and tumor growth
Masaki Terabe, Jong Myun Park, Jay A. Berzofsky
Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease
Suzanne Ostrand-Rosenberg, Pratima Sinha, Virginia Clements, Samudra I. Dissanayake, Seth Miller, Cordula Davis, Erika Danna
Immunization with a plant-produced colorectal cancer antigen
Thorsten Verch, D. Craig Hooper, Anatoly Kiyatkin, Zenon Steplewski, Hilary Koprowski
T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool
Shirley M. Bartido, Karen Zier
Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma
Reiko F. Irie, David W. Ollila, Steven O’Day, Donald L. Morton
In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein
Wenxue Ma, Hai Yu, Qingqing Wang, Jianfang Bao, Jie Yan, Hongchuan Jin
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
Peter Hersey, Scott W. Menzies, Gary M. Halliday, Tam Nguyen, Margaret L. Farrelly, Chitra DeSilva, Margaret Lett